Healthcare & Life Sciences

Macromoltek

South Korea

series-b

Stage

Investors

About

Macromoltek develops polymer-based delivery systems designed to enhance the cellular delivery and stability of RNA and DNA nucleic acid therapeutics.

Funding rounds, investor list, and risk signals — unlock with a subscription.